S. Albenque-Rubio, J. Guillon, P. Agnamey, C. Damiani, S. Savrimoutou, R. Mustière, N. Pinaud, S. Moreau, J-L. Mergny, L. Ronga, I. Kanavos, M. Marchivie, S. Moukha, P. Dozolme, P. Sonnet and A. Cohen
Drugs and Drug Candidates, 3 (3), 615-637, https://doi.org/10.3390/ddc3030035
"Crystal Structure of Bis(1-butyl-1-methypyrrolidinium) Perthiodicarbonate Complex".
N. Pinaud, Y. Danten, M. Marchivie, M. Besnard, I. Cabaco, J. Guillon
Molbank, (3) M1849, DOI:10.3390/M1849
"Biochemical and Functional Characterization of SARS-CoV-2 Unique Domain (SUD) in Nsp3-RNA G4 Complexes and Therapeutic Properties of G4-Ligands Inhibiting Their Formation".
J. Guillon, S. Savrimoutou, A. Gaouar, S. Albenque-Rubio, S. Moreau, O. Helynck, J. Chiaravalli, R. Boudria-Souilah, N. Pinaud, L. Ronga, J.-L. Mergny, H. Munier-Lehmann, M. Lavigne.
Drugs and Drug Candidates, 3 (1), 235-236, https://doi.org/10.3390/ddc3010013, 2024.
"New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline derivatives: Synthesis and biological evaluation as novel anti-cancer agents by targeting G-quadruplex".
J. Guillon, M. Le Borgne, V. Milano, A. Guedin-Beaurepaire, S. Moreau, N. Pinaud, L. Ronga, S. Savrimoutou, S. Albenque-Rubio, M. Marchivie, H. Kalout, C. Walker, L. Chevallier, C. Buré, E. Largy, V. Gabelica, J.-L. Mergny, V. Baylot, J. Ferrer, Y. Idrissi, E. Chevret, D. Cappellen, V. Desplat, Z. Schelz, I. Zupkó.
Pharmaceuticals, 17 (1), 30 (29 p.), https://doi.org/10.3390/ph17010030, 2024.
"Potassium 6-oxo-7,13,16,22-tetraazatetracyclo[12.6.2.18,12.017,21]tricosa-1(20),8(23),9,11,14,16,18,21-octaen-2-yne-15-carboxylate".
C. Blouet, S. Letast, T. Robert, S. Bach, N. Pinaud, N. Joubert, M.-C. Viaud-Massuard, J. Guillon, C. Logé, C. Denevault-Sabourin.
Molbank, 2023 (4), M1735 (9 p.), doi.org/10.3390/M1735, 2023.
"Synthesis and antimalarial evaluation of new 1,3,5-tris[(4-(substituted-aminomethyl)phenyl)methyl]benzene derivatives, a novel alternative antiparasitic scaffold".
S. Albenque-Rubio, J. Guillon, A. Cohen, P. Agnamey, S. Savrimoutou, S. Moreau, J.-L. Mergny, L. Ronga, I. Kanavos, S. Moukha, P. Dozolme, P. Sonnet.
Drugs and Drug Candidates, 2 (3), 653-672, 2023.
"Development, synthesis and antiprotozoal assessment of new substituted diquinolinyl-pyridine derivatives as antiparasitic agents by potential G-4 binding".
R. N. Das, A. Cohen, C. Boudot, S. Savrimoutou, S. Albenque-Rubio, S. Moreau, J.-L. Mergny, L. Ronga, I. Kanavos, C. Descamps, V. Verdier, P. Agnamey, C. Mullié, B. Courtioux, P. Sonnet, J. Guillon.
Acta Scientific Pharmaceutical Sciences, 7 (7), 15-33, 2023.
"Synthesis, Crystal Structure and Anti-leukemic Activity of (E)-Pyrrolo[1,2-a]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one".
J. Guillon, S. Savrimoutou, S. Albenque-Rubio, N. Pinaud, N. Fillová, S. Moreau, V. Baylot, V. Desplat.
Molbank, 2023 (3), M1691 (7 p.), doi.org/10.3390/M1691, 2023.
"Synthesis and antiprotozoal evaluation of new 2,9-bis[(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives by targeting G-quadruplex, an interesting pharmacophore against drug efflux".
J. Guillon, A. Cohen, S. Monic, C. Boudot, S. Savrimoutou, S. Albenque-Rubio, S. Moreau, A. Dassonville-Klimpt, J.-L. Mergny, L. Ronga, M. Bernabeu de Maria, N. Tyurin-Schmitt, P. Parrens, A. Labarthe, V. Gomez, S. Moukha, P. Dozolme, N. Azas, V. Gabelica, P. Agnamey, C. Damiani, A. Totet, C. Mullié, B. Courtioux, P. Sonnet.
Acta Scientific Pharmaceutical Sciences, 7 (2), 50-65, 2023.
"Première année de fonctionnement du Parcours Accès Spécifique Santé (PASS) de l’université de Bordeaux : caractérisation et identification des facteurs de réussite pour la validation du PASS et l’entrée dans la filière médecine".
I. Dupin, S. Barandon, C. Bertrand, L. Bordenave, V. Chassaing, J.-B. Corcuff, P. Dubus, N. C. Duclos, J. Guillon, M. Mamani-Matsuda, B. Müller, J.-L. Pellegrin, A. Alioum. Pédagogie Médicale, 23 (4), 181-192, 2022.
"Design, synthesis, biophysical and antiprotozoal evaluation of new promising 2,9-bis[(substituted-aminomethyl)]-4,7-phenyl-1,10-phenanthroline derivatives by targeting G-quadruplex, a potential alternative to drug efflux".
J. Guillon, A. Cohen, C. Boudot, S. Monic, S. Savrimoutou, S. Moreau, S. Albenque-Rubio, C. Lafon-Schmaltz, A. Dassonville-Klimpt, J.-L. Mergny, L. Ronga, M. Bernabeu de Maria, J. Lamarche, C. Dal Lago, E. Largy, V. Gabelica, S. Moukha, P. Dozolme, P. Agnamey, N. Azas, C. Mullié, B. Courtioux, P. Sonnet.
Pathogens, 11 (11), 1339 (25 p.). doi.org/10.3390/pathogens11111339, 2022.
"Synthesis, crystal structure and anti-leukemic activity of 1,3-dihydro-1-{1-[4-(4-phenylpyrrolo[1,2-a]quinoxalin-3-yl)benzyl]piperidin-4-yl}-2H-benzimidazol-2-one".
J. Guillon, S. Savrimoutou, S. Albenque-Rubio, N. Pinaud, S. Moreau, V. Desplat.
Molbank, 2022 (1), M1333 (7 p.), doi.org/10.3390/M1333, 2022.
"Design, synthesis, and characterization of novel aminoalcohol quinolines with strong in vitro antimalarial activity".
A. Dassonville-Klimpt, J. Schneider, C. Damiani, C. Tisnerat, S. Klieber, A. Cohen, N. Azas, M. Marchivie, J. Guillon, C. Mullié, P. Agnamey, A. Totet, N. Taudon, A. Pellet, B. Pradines, P. Sonnet.
European Journal of Medicinal Chemistry, 228, 113981 (26 p.), 2022.
"G-Quadruplexes in helminth parasites".
A. Cantara, Y. Luo, M. Dobrovolná, N. Bohalova, M. Fojta1, D. Verga, L. Guittat, A. Cucchiarini, S. Savrimoutou, C. Häberli, J. Guillon, J. Keiser, V. Brázda, J.-L. Mergny.
Nucleic Acids Research, 50 (5), 2719-2735, 2022.
"Crystal Structure of Crystal Structure of 1-(3-Ferrocenyl-2-methylpyrrolo[1,2-a]quinoxalin-4-yl)piperazi-4-ium Chloride".
J. Guillon, N. Pinaud, S. Savrimoutou, M. Marchivie, S. Moreau, S. Albenque-Rubio, P. Sonnet.
X-ray Structure Analysis Online, 37 (10), 65-67, 2021.
"SARS-CoV-2 Nsp3 Unique Domain SUD interacts with Guanine quadruplexes". M. Lavigne, O. Helynck, P. Rigolet, M. Nowakowski, S. Brûlé, S. Hoos, B. Raynal, L. Guittat, C. Beauvineau, S. Petres, A. Granzhan, J. Guillon, G. Pratviel, M.-P. Teulade-Fichou, P. England, J.-L. Mergny, H. Munier-Lehmann.
Nucleic Acids Research, 49 (13), 7695-7712, 2021.
"Design, synthesis and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex".
J. Guillon, C. Denevault-Sabourin, E. Chevret, M. Brachet-Botineau, V. Milano, A. Guedin-Beaurepaire, S. Moreau, L. Ronga, S. Savrimoutou, S. Rubio, J. Ferrer, J. Lamarche, J.-L. Mergny, M.-C. Viaud-Massuard, M. Ranz, E. Largy, V. Gabelica, F. Rosu, F. Gouilleux, V. Desplat.
Archiv der Pharmazie, 354 (8), e2000450, doi.org/10.1002/ardp.202000450, 2021.
"New quinoxaline derivatives as dual Pim-1/2 kinase inhibitors: design, synthesis and biological evaluation".
B. Oyallon, M. Brachet-Botineau, C. Logé, T. Robert, S. Bach, S. Ibrahim, W. Raoul, C. Croix, P. Berthelot, J. Guillon, N. Pinaud, F. Gouilleux, M.-C. Viaud-Massuard, C. Denevault-Sabourin.
Molecules, 26 (4), 867 (20 p.), doi.org/10.3390/molecules26040867, 2021.
"Synthesis, Optimization, Antifungal Activity, Selectivity and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols".
N. Lebouvier, F. Pagniez, Y. Min Na, D. Shi, P. Pinson, M. Marchivie, J. Guillon, T. Hakki, R. Bernhardt, S. Wah Yee, C. Simons, M.-P. Lézé, R. W. Hartmann, A. Mularoni, G. Le Baut, R. Abagyan, P. Le Pape, M. Le Borgne.
Pharmaceuticals, 13 (8), 186 (32 p.), doi:10.3390/ph13080186, 2020.
"Triarylpyridine Compounds and Chloroquine Act in Concert to Trigger Lysosomal Membrane Permeabilization and Cell Death in Cancer Cells".
J. Beauvarlet, R. N. Das, K. Alvarez-Valadez, I. Martins, A. Muller, E. Darbo, E. Richard, P. Soubeyran, G. Kroemer, J. Guillon, J.-L. Mergny, M. Djavaheri-Mergny.
Cancers, 12 (6), 1621 (21 p.), doi:10.3390/cancers12061621, 2020.
"1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one : Synthesis, Crystal Structure and Anti-leukemic Activity". J. Guillon, S. Savrimoutou, S. Rubio, S. Moreau, N. Pinaud, M. Marchivie, V. Desplat.
Molbank, 2020 (1), M1113 (7 p.), doi.org/10.3390/M1113, 2020.
"Enantiopure substituted pyridines as promising antimalarial drug candidates".
G. Bentzinger, E. Pair, J. Guillon, M. Marchivie, C. Mullié, P. Agnamey, A. Dassonville-Klimpt, P. Sonnet.
Tetrahedron, 76, 131088, 2020.
"Synthesis of new piperazinyl-pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of Candida albicans multidrug transporters by a Buchwald-Hartwig cross-coupling reaction".
J. Guillon, S. Nim, S. Moreau, L. Ronga, S. Savrimoutou, E. Thivet, M. Marchivie, A. Di Pietro, R. Prasade, M. Le Borgne.
RSC Advances, 10 (5), 2915-2931, 2020.
"Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives".
J. Guillon, A. Cohen, C. Boudot, A. Valle, V. Milano, R. N. Das, A. Guedin, S. Moreau, L. Ronga, S. Savrimoutou, L. Basmaciyan, M. Demourgues, E. Reviriego, S. Rubio, S. Ferriez, P. Agnamey, C. Pauc, S. Moukha, P. Dozolme, S. Da Nascimento, P. Laumaillé, A. Bouchut, N. Azas, J.-L. Mergny, C. Mullié, P. Sonnet, B. Courtioux.
Journal of Enzyme Inhibition and Medicinal Chemistry, 35 (1), 432-459, 2020.
"New 6-Formyl-oxazolo[3,2-a]pyrimidine Derivatives : Synthesis and Evaluation as Potential Src Kinase Inhibitors".
J. Guillon, F. Hallé, S. Savrimoutou, S. Moreau, D.-H. Caignard, P. Sonnet.
Acta Scientific Pharmaceutical Sciences, 3 (12), 33-36, 2019.
"Crystal Structure of 6,7-Dihydro-5a,7a,13,14-tetraaza-pentaphene-5,8-dione".
J. Guillon, M. de Fatima Pereira-Rosenfeld, N. Pinaud, T. Besson, V. Thiéry, L. Picot, M. Marchivie.
X-ray Structure Analysis Online, 35 (10), 57-59, 2019.
"Synthesis and antiparasitic evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives".
J. Guillon, A. Cohen, R. Nath Das, C. Boudot, S. Moreau, L. Ronga, S. Savrimoutou, L. Elmi, S. Rubio, A. Dassonville-Klimpt, N. Azas, B. Courtioux, J.-L. Mergny, C. Mullié, P. Sonnet.
Pharmaceuticals, 12 (2), 73 (p.24-25), 2019.
"Synthesis of 1H-3-{4-[(3-Dimethylaminopropyl)aminomethyl]phenyl}-2-phenylindole and Evaluation of Its Antiprotozoal Activity".
J. Guillon, C. Boudot, A. Cohen, S. Savrimoutou, S. Rubio, V. Milano, M. Marchivie, N. Azas, C. Mullié, P. Sonnet, B. Courtioux.
Molbank, 2019 (2), M1060 (9 p.), doi:10.3390/M1060, 2019.
"Peptide-based drug-delivery systems in biotechnological applications: recent advances and perspectives".
D. Tesauro, A. Accardo, C. Diaferia, V. Milano, J. Guillon, L. Ronga, F. Rossi
Molecules, 24 (2), 351 (27 p.), doi.org/10.3390/molecules24020351, 2019.
"Synthesis, Crystal Structure and Anti-leukemic Activity of 4-{4-[(4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-3-phenyl-3H-pyrrolo[2,3-c]quinoline".
J. Guillon, S. Moreau, V. Desplat, M. Vincenzi, N. Pinaud, S. Savrimoutou, S. Rubio, L. Ronga, F. Rossi, M. Marchivie.
Journal of Chemical Crystallography, 49 (2), 106-112, 2019.
"1-Methyl-3-{4-[(4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-2-phenylindole".
J. Guillon, S. Savrimoutou, S. Rubio, V. Desplat.
Molbank, 2018 (4), M1023 (6 p.), doi : org/10.3390/M1023, 2018.
"Crystal Structure and Identification of a Pyrimido[6,1-b][1,3]oxazin-6-one Derivative from the Reaction of Acrolein with 5-(Phenoxymethyl)-2-amino-2-oxazoline".
J. Guillon, S. Rubio, S. Savrimoutou, F. Hallé, S. Moreau, P. Sonnet.
Comptes Rendus Chimie, 21 (11), 987-992, 2018.
"Crystal Structure of 2,8-Bis(trifluoromethyl)-4-vinylquinoline".
J. Guillon, A. Dassonville-Klimpt, S. Moreau, P. Laumaille, M. Marchivie, P. Sonnet.
X-ray Structure Analysis Online, 34 (4), 15-16, 2018.
"Synthesis and Antimalarial Activity of New Enantiopure Aminoalcoholpyrrolo[1,2-a]quinoxalines".
A. Jonet, J. Guillon, C. Mullié, A. Cohen, G. Bentzinger, S. Hutter, N. Azas, S. Moreau, S. Savrimoutou, P. Agnamey, A. Dassonville-Klimpt, P. Sonnet.
Medicinal Chemistry, 14 (3), 293-303, 2018.
"Design, synthesis and biological evaluation of new substituted diquinolinyl-pyridine ligands as anticancer agents by targeting G-quadruplex".
R. N. Das, E. Chevret, V. Desplat, S. Rubio, J.-L. Mergny, J. Guillon.
Molecules, 23 (1), 81 (15 p.), doi:10.3390/molecules23010081, 2018.
"Design, synthesis, and antiprotozoal evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives".
J. Guillon, A. Cohen, R. Nath Das, C. Boudot, N. Meriem Gueddouda, S. Moreau, L. Ronga, S. Savrimoutou, L. Basmaciyan, C. Tisnerat, S. Mestanier, S. Rubio, S. Amaziane, A. Dassonville-Klimpt, N. Azas, B. Courtioux, J.-L. Mergny, C. Mullié, P. Sonnet.
Chemical Biology & Drug Design, 91 (5), 974-995, 2018.
"Crystal Structure of N-(7-{[2-(dimethylamino)ethyl]amino}-1-methyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-3,4,5-trimethoxybenzamide".
J. Guillon, D. Montoir, M. Marchivie, M. Duflos, M.-A. Bazin.
X-ray Structure Analysis Online, 33 (7), 45-47, 2017.
"Synthesis and antiproliferative effect of new ethyl 4-(4-substitutedpiperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives on human leukemic cells".
V. Desplat, M. Vincenzi, R. Lucas, S. Moreau, S. Savrimoutou, S. Rubio, N. Pinaud, D. Bigat, E. Enriquez, M. Marchivie, S. Routier, P. Sonnet, F. Rossi, L. Ronga, J. Guillon.
ChemMedChem, 12 (12), 940-953, 2017.
"Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives".
J. Guillon, A. Cohen, N. M. Gueddouda, R. Nath Das, S. Moreau, L. Ronga, S. Savrimoutou, L. Basmacyian, A. Monnier, M. Monget, S. Rubio, T. Garnerin, N. Azas, J.-L. Mergny, C. Mullié, P. Sonnet.
Journal of Enzyme Inhibition and Medicinal Chemistry, 32 (1), 547-563, 2017.
"Design, synthesis, and evaluation of the cytotoxic activity of new 3-{4-[(4-(substituted)piperidin-1-yl)benzyl]}-2-phenylindoles in myeloid and lymphoid leukemia cell lines".
J. Guillon, M. Vincenzi, N. Pinaud, L. Ronga, F. Rossi, S. Savrimoutou, S. Moreau, M. Marchivie, V. Desplat.
Pharmaceuticals, 10 (1), 17 (p.14-15), 2017.
"Design, synthesis, and evaluation of 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives as G-quadruplex ligands".
N. M. Gueddouda, M. Rosales Hurtado, S. Moreau, L. Ronga, S. Savrimoutou, S. Rubio, A. Marchand, R. N. Das, O. Mendoza, M. Marchivie, L. Elmi, A. Chansavang, V. Desplat, V. Gabelica, A. Bourdoncle, J.-L. Mergny, J. Guillon.
ChemMedChem, 12 (2), 146-160, 2017.
"Crystal Structure of 7-Amino-4-iodo-3-propyl-1H-isochromen-1-one".
J. Guillon, L. Ronga, M. Marchivie, V. Lisowski.
X-ray Structure Analysis Online, 32 (10), 45-46, 2016.
"Synthesis and Crystal Structure of 3-{4-[(4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-2-phenylindole".
J. Guillon, M. Vincenzi, N. Pinaud, L. Ronga, F. Rossi, S. Savrimoutou, S. Moreau, V. Desplat, M. Marchivie.
Structural Chemistry & Crystallography Communication, 2 (1), 8 (6 p.), 2016.
"Crystal Structure of (E)-1-(3,4-Methylenedioxy-6-fluorophenyl)-2-nitropropene".
J. Guillon, L. Ronga, M. Marchivie, S. Moreau.
X-ray Structure Analysis Online, 32 (5), 23-24, 2016.
"Overcoming cyclodimerization in the synthesis of new anti-angiogenic cyclic peptide".
S. Rubio, J. Clarhaut, E. Péeraudeau, M. Vincenzi, C. Soum, J. Guillon, S. Papot, L. Ronga.
Biopolymers: Peptide Science, 106 (3), 368-375, 2016.
"Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines".
V. Desplat, M. Vincenzi, R. Lucas, S. Moreau, S. Savrimoutou, N. Pinaud, J. Lesbordes, E. Peyrilles, M. Marchivie, S. Routier, P. Sonnet, F. Rossi, L. Ronga, J. Guillon.
European Journal of Medicinal Chemistry, 113, 214-227, 2016.
"Design, Synthesis and Antimalarial Activity of Some New Aminoalcohol-pyrrolo[1,2-a]quinoxaline Derivatives".
J. Guillon, S. Moreau, L. Ronga, L. Basmacyian, S. Rubio, A. Cohen, G. Bentzinger, S. Savrimoutou, N. Azas, C. Mullié, P. Sonnet.
Letters in Drug Design & Discovery, 13 (9), 932-942, 2016.
"Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehicles".
M. Vincenzi, A. Accardo, S. Costantini, S. Scala, L. Portella, A. Trotta, L. Ronga, J. Guillon, M. Leone, G. Colonna, F. Rossia, D. Tesauro.
Molecular BioSystems, 11 (11), 2925-2932, 2015.
"Conformational Ensembles Explored Dynamically from Disordered Peptides Targeting Chemokine Receptor CXCR4".
M. Vincenzi, S. Costantini, S. Scala, D. Tesauro, A. Accardo, M. Leone, G. Colonna, J. Guillon, L. Portella, A. Maria Trotta, L. Ronga, F. Rossi.
International Journal of Molecular Sciences, 16 (6), 12159-12173, 2015.
"Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and nontoxic inhibitors stimulating basal ATPase activity".
G. Jabor Gozzi, Z. Bouaziz, E. Winter, N. Daflon-Yunes, M. Honorat, N. Guragossian, C. Marminon, G. Valdameri, A. Bollacke, J. Guillon, N. Pinaud, M. Marchivie, S. M. Cadena, J. Jose, M. Le Borgne, A. Di Pietro.
Drug Design, Development and Therapy, 9, 3481–3495, 2015.
"Overcoming cyclodimerization in the synthesis of new anti-angiogenic cyclic peptide".
S. Rubio, J. Clarhaut, E. Péeraudeau, M. Vincenzi, C. Soum, J. Guillon, S. Papot, L. Ronga.
Biopolymers: Peptide Science, 106 (3), 368-375, 2016.
"Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines".
V. Desplat, M. Vincenzi, R. Lucas, S. Moreau, S. Savrimoutou, N. Pinaud, J. Lesbordes, E. Peyrilles, M. Marchivie, S. Routier, P. Sonnet, F. Rossi, L. Ronga, J. Guillon.
European Journal of Medicinal Chemistry, 113, 214-227, 2016.
"Design, Synthesis and Antimalarial Activity of Some New Aminoalcohol-pyrrolo[1,2-a]quinoxaline Derivatives".
J. Guillon, S. Moreau, L. Ronga, L. Basmacyian, S. Rubio, A. Cohen, G. Bentzinger, S. Savrimoutou, N. Azas, C. Mullié, P. Sonnet.
Letters in Drug Design & Discovery, 13 (9), 932-942, 2016.
"Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehicles".
M. Vincenzi, A. Accardo, S. Costantini, S. Scala, L. Portella, A. Trotta, L. Ronga, J. Guillon, M. Leone, G. Colonna, F. Rossia, D. Tesauro.
Molecular BioSystems, 11 (11), 2925-2932, 2015.
"Conformational Ensembles Explored Dynamically from Disordered Peptides Targeting Chemokine Receptor CXCR4".
M. Vincenzi, S. Costantini, S. Scala, D. Tesauro, A. Accardo, M. Leone, G. Colonna, J. Guillon, L. Portella, A. Maria Trotta, L. Ronga, F. Rossi.
International Journal of Molecular Sciences, 16 (6), 12159-12173, 2015.
"Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and nontoxic inhibitors stimulating basal ATPase activity".
G. Jabor Gozzi, Z. Bouaziz, E. Winter, N. Daflon-Yunes, M. Honorat, N. Guragossian, C. Marminon, G. Valdameri, A. Bollacke, J. Guillon, N. Pinaud, M. Marchivie, S. M. Cadena, J. Jose, M. Le Borgne, A. Di Pietro.
Drug Design, Development and Therapy, 9, 3481–3495, 2015.
"Synthesis, biological evaluation and molecular modeling of substituted indeno[1,2-b]indoles as inhibitors of human protein kinase CK2".
F. Al Chab, L. Ettouati, Z. Bouaziz, A. Bollacke, J.-G. Delcros, C. G. W. Gertzen, H. Gohlke, N. Pinaud, M. Marchivie, J. Guillon, B. Fenet, J. Jose, M. Le Borgne.
Pharmaceuticals, 8 (2), 279-302, 2015.
"Crystal Structure of a Fluoro Analogue of 3,4-(Methylenedioxy)amphetamine".
J. Guillon, N. Pinaud, M. Marchivie, L. Ronga, A. Benazzouz, S. Moreau.
X-ray Structure Analysis Online, 31, 23-24, 2015.
"Converting Potent Indeno[1,2-b]indole Inhibitors of Protein Kinase CK2 into Selective Inhibitors of the Breast Cancer Resistance Protein ABCG2".
G. J. Gozzi, Z. Bouaziz, E. Winter, N. Daflon-Yunes, D. Aichele, A. Nacereddine, C. Marminon, G. Valdameri, W. Zeinyeh, A. Bollacke, J. Guillon, A. Lacoudre, N. Pinaud, S. M. Cadena, J. Jose, M. Le Borgne, A. Di Pietro.
Journal of Medicinal Chemistry, 58, 265-277, 2015.
"Design, Synthesis and Biological Evaluation of Novel 4-Alkapolyenylpyrrolo[1,2-a]quinoxalines as Antileishmanial Agents – Part III".
L. Ronga, M. Del Favero, A. Cohen, C. Soum, P. Le Pape, S. Savrimoutou, N. Pinaud, C. Mullié, S. Daulouede, P. Vincendeau, N. Farvacques, P. Agnamey, F. Pagniez, S. Hutter, N. Azas, P. Sonnet, J. Guillon.
European Journal of Medicinal Chemistry, 81, 378-393, 2014.
"Structural elucidation of two photolytic degradation products of tetrabenazine".
Z. Bourezga, N. Cartiserb, L. Ettouatib, J. Guillon, A. Lacoudre, N. Pinaud, M. Le Borgne, H. Fessia.
Journal of Pharmaceutical and Biomedical Analysis, 91, 138-143, 2014.
"Antitumor activity of semisynthetic derivatives of Aconitum alkaloids".
A. Chodoeva, J.-J. Bosc, L. Lartigue, J. Guillon, C. Auzanneau, P. Costet, A. Zurdinov, C. Jarry, J. Robert.
Investigational New Drugs, 32 (1), 60-67, 2014.
